These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 86392)

  • 1. Bleomycin pharmacokinetics in man. I. Intravenous administration.
    Alberts DS; Chen HS; Liu R; Himmelstein KJ; Mayersohn M; Perrier D; Gross J; Moon T; Broughton A; Salmon SE
    Cancer Chemother Pharmacol; 1978; 1(3):177-81. PubMed ID: 86392
    [No Abstract]   [Full Text] [Related]  

  • 2. Bleomycin pharmacokinetics in man. II. Intracavitary administration.
    Alberts DS; Chen HS; Mayersohn M; Perrier D; Moon TE; Gross JF
    Cancer Chemother Pharmacol; 1979; 2(2):127-32. PubMed ID: 93985
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetics of bleomycin after im administration in man.
    Oken MM; Crooke ST; Elson MK; Strong JE; Shafer RB
    Cancer Treat Rep; 1981; 65(5-6):485-9. PubMed ID: 6165473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of variations in renal function on the clinical pharmacology of bleomycin administered as an iv bolus.
    Crooke ST; Comis RL; Einhorn LH; Strong JE; Broughton A; Prestayko AW
    Cancer Treat Rep; 1977 Dec; 61(9):1631-6. PubMed ID: 74282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on the administration of bleomycin in a nude mouse model of squamous cell carcinoma of the mouth. 1. 57Co-bleomycin pharmacokinetics after intratumor and intravenous administration].
    Henke E; Fröhlich M; Gens J; Arnold W; Naundorf A; Franke WG; Seela W
    Radiobiol Radiother (Berl); 1984; 25(1):143-52. PubMed ID: 6203135
    [No Abstract]   [Full Text] [Related]  

  • 6. [57Co-bleomycin kinetics after local and systemic administration].
    Bier J; Benders P; Bitter K
    Dtsch Zahnarztl Z; 1980 Jan; 35(1):96-8. PubMed ID: 6157513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bleomycin disposition in children with cancer.
    Yee GC; Crom WR; Lee FH; Smyth RD; Evans WE
    Clin Pharmacol Ther; 1983 May; 33(5):668-73. PubMed ID: 6188571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous infusion of bleomycin--a practical alternative to intravenous infusion.
    Harvey VJ; Slevin ML; Aherne GW; Littleton P; Johnston A; Wrigley PF
    J Clin Oncol; 1987 Apr; 5(4):648-50. PubMed ID: 2435856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics of bleomycin in man.
    Kramer WG; Feldman S; Broughton A; Strong JE; Hall SW; Holoye PY
    J Clin Pharmacol; 1978 Jul; 18(7):346-52. PubMed ID: 78932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinical trial of intravenous bleomycin in the treatment of brain tumors.
    Takeuchi K
    Int J Clin Pharmacol Biopharm; 1975 Dec; 12(4):419-26. PubMed ID: 54345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed-release bleomycin. Comparative pharmacology of bleomycin oil suspension and bleomycin in saline.
    Slevin ML; Harvey VJ; Aherne GW; Burton NK; Johnston A; Wrigley PF
    Cancer Chemother Pharmacol; 1984; 13(1):19-21. PubMed ID: 6203661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacology of bleomycin following intravenous infusion as determined by radioimmunoassay.
    Broughton A; Strong JE; Holoye PY; Bedrossian CW
    Cancer; 1977 Dec; 40(6):2772-8. PubMed ID: 73408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetics of the antitumor antibiotic bleomycetin in cancer patients given the preparation by different methods].
    Smolianskaia AZ; Spitsyna TA; Manziuk LV
    Antibiotiki; 1984 Aug; 29(8):616-9. PubMed ID: 6207770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of bleomycin in man. III. Bleomycin 57Co Vs bleomycin.
    Alberts DS; Chen HS; Woolfenden JM; Moon TE; Chang SY; Hall JN; Himmelstein KJ; Gross J; Salmon SE
    Cancer Chemother Pharmacol; 1979; 3(1):33-40. PubMed ID: 93987
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the clinical pharmacology of bleomycin.
    Crooke ST; Comis RI; Einhorn LH; Strong JE; Broughton A; Prestayko AW
    Recent Results Cancer Res; 1978; 63():219-29. PubMed ID: 81504
    [No Abstract]   [Full Text] [Related]  

  • 16. [Investigations on the accumulation of radio-bleomycin in gynaecological tumors (author's transl)].
    Lange J; Lange S; Kreuzer G; Haubold U
    Geburtshilfe Frauenheilkd; 1976 May; 36(5):436-8. PubMed ID: 58804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bleomycin (NSC-125066): phase I clinical study.
    Sonntag RW
    Cancer Chemother Rep; 1972 Apr; 56(2):197-205. PubMed ID: 4114485
    [No Abstract]   [Full Text] [Related]  

  • 18. A pharmacokinetic evaluation of IM administration of bleomycin oil suspension.
    Davy M; Paus E; Lehne G
    Cancer Chemother Pharmacol; 1985; 14(3):274-6. PubMed ID: 2581717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bleomycin therapy].
    Brufman G; Biran S; Hochman A
    Harefuah; 1974 Jan; 86(2):65-7. PubMed ID: 4133114
    [No Abstract]   [Full Text] [Related]  

  • 20. [Phase I and phase II studies of a new bleomycin (pepleomycin) (author's transl)].
    Miura T; Katayama K; Wada T
    Jpn J Antibiot; 1979 Feb; 32(2):265-77. PubMed ID: 86623
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.